Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 5

    1.

    Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice.

    Olcott AP, Tian J, Walker V, Dang H, Middleton B, Adorini L, Washburn L, Kaufman DL.

    J Immunol. 2005 Aug 1;175(3):1991-9.PMID: 16034144 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A salen-manganese catalytic free radical scavenger inhibits type 1 diabetes and islet allograft rejection.

    Olcott AP, Tocco G, Tian J, Zekzer D, Fukuto J, Ignarro L, Kaufman DL.

    Diabetes. 2004 Oct;53(10):2574-80.PMID: 15448086 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Temporal changes occur in the neuroendocrine control of gonadotropin secretion in aging female rats: role of progesterone.

    Tsai HW, LaPolt PS, Olcott AP, Lu JK.

    Biol Reprod. 2004 Sep;71(3):845-52. Epub 2004 May 26.PMID: 15163616 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Antigen-based immunotherapy drives the precocious development of autoimmunity.

    Tian J, Olcott AP, Kaufman DL.

    J Immunol. 2002 Dec 1;169(11):6564-9.PMID: 12444168 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Infectious Th1 and Th2 autoimmunity in diabetes-prone mice.

    Tian J, Olcott AP, Hanssen LR, Zekzer D, Middleton B, Kaufman DL.

    Immunol Rev. 1998 Aug;164:119-27. Review.PMID: 9795770 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...